Abstract/Details

Curcumin reactivates epigenetically silenced tumor suppressor gene tissue factor pathway inhibitor-2 in hepatocellular carcinoma cells


2010 2010

Other formats: Order a copy

Abstract (summary)

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most fatal, with a rising incidence in the US as a result of the increase in alcoholic liver disease and obesity. Current therapeutic strategies are unsatisfactory with poor treatment outcomes and efficacious therapies are acutely needed for better management of this deadly disease. Curcumin, a phenolic compound from the rhizome of the plant Curcuma longa has been shown to inhibit growth and induce cell death in various types of cancer cells including HCC. However, the anti-HCC mode of action of curcumin has not yet been elucidated.

In HCC, aberrant promoter methylation and histone deacetylation are implicated in the inactivation of tumor suppressor genes which has a significant impact on carcinogenesis. Tissue factor pathway inhibitor-2 (TFPI-2), a Kunitz-type serine protease inhibitor, is a tumor suppressor gene that is frequently epigenetically silenced in human HCC and HCC cell lines. Restoration of TFPI-2 expression in tumor tissue has been shown to not only inhibit invasion, tumor growth, metastasis and angiogenesis but also induce apoptosis. We examined the effects of curcumin on tumor suppressor genes in HCC and observed robust reactivation of TFPI-2 in HepG2 cells upon curcumin treatment. We confirmed that TFPI-2 was under epigenetic control in HepG2 cells by using demethylating agent 5-Aza-2'deoxycytidine (5-AZA) and histone deacetylase inhibitor trichostatin A (TSA), both of which induced gene expression. Further, we investigated the epigenetic modifications at the TFPI-2 promoter and the alterations induced by curcumin in these epigenetic states. Histone H3 acetylation at the transcription factor binding sites of the TFPI-2 promoter region was increased by curcumin and correlated with the induction of gene expression. The reactivation of TFPI-2 also corresponded with a decrease in cell invasiveness and increase in cell death in HepG2 cells. Overall, our data strongly suggest that curcumin can reverse the epigenetic alterations at the TFPI-2 promoter and thus, reactivate this silenced tumor suppressor gene. These results support a potential therapeutic role for curcumin in the management of HCC.

Indexing (details)


Subject
Genetics;
Pharmacology;
Oncology
Classification
0369: Genetics
0419: Pharmacology
0992: Oncology
Identifier / keyword
Health and environmental sciences; Biological sciences
Title
Curcumin reactivates epigenetically silenced tumor suppressor gene tissue factor pathway inhibitor-2 in hepatocellular carcinoma cells
Author
Moghe, Akshata
Number of pages
41
Publication year
2010
Degree date
2010
School code
0110
Source
MAI 49/03M, Masters Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9781124374932
University/institution
University of Louisville
University location
United States -- Kentucky
Degree
M.S.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
1487369
ProQuest document ID
820740171
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/820740171
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.